BlossomHill Therapeutics
Logotype for BlossomHill Therapeutics Inc

BlossomHill Therapeutics (BLSM) investor relations material

BlossomHill Therapeutics Corporate presentation summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for BlossomHill Therapeutics Inc
Corporate presentation summary6 Aug, 2026

Strategic vision and leadership

  • Focused on designing novel, orally available precision medicines for cancer with significant unmet needs.

  • Leadership team has a strong track record in developing FDA-approved cancer therapies.

  • Emphasizes precision drug design based on deep understanding of target biology and protein structure.

Pipeline overview and milestones

  • Pipeline includes BH-30643 (OMNI-EGFR inhibitor), BH-30236 (CLK inhibitor), and BH-501284 (pan-KRAS inhibitor).

  • Multiple near-term milestones: pivotal Phase 2 for BH-30643 in Q1 2027, IND for BH-501284 in Q1 2027, and Phase 1 data for BH-30236 in 1H 2027.

  • Estimated cash runway extends to Q1 2028, with $116M cash at end of Q1 2026.

BH-30643 (OMNI-EGFR inhibitor) clinical progress

  • Demonstrated high potency against classical, atypical, and exon20ins EGFR mutations, including C797S resistance.

  • Phase 1/2 SOLARA trial shows confirmed responses in C797S-positive NSCLC, with ORR of 53% in chemo-naive and 42% in chemo-treated patients.

  • Early activity in TKI-naive patients with 78% ORR and 96% DCR; notable CNS activity and ctDNA clearance.

  • Safety profile supports further development, with most adverse events manageable and no grade 5 TRAEs.

  • EOP1 meeting planned for Q4 2026 to enable seamless transition to registrational Phase 2 trial.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.
BlossomHill Therapeutics
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Explore our global coverage